More sensitive tumours may not require such high drug levels and it is unclear whether this discrepancy in drug exposure was responsible for the failure to demonstrate an effect on RB phosphorylation and cyclin D1 in peripheral blood mononuclear cells. The gene discussed is CCND1; the disease is neoplasm.